Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scheinberg

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activityL C Pagliaro, B Liu, R Munker, et al.
Molecular Immunology|August 1, 1995
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityT K Nikula, M Bocchia, M J Curcio, et al.
Nuclear Medicine and Biology|April 1, 1995
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.
Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.
Leukemia Research|May 1, 1997
Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cellsM Bocchia, Q Xu, U Wesley, et al.
Leukemia|January 1, 1996
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemiaP G Maslak, M A Weiss, E Berman, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
The Journal of Experimental Medicine|June 1, 1996
The multidrug resistance phenotype confers immunological resistanceJ H Weisburg, M Curcio, P C Caron, et al.
Acta Haematologica|January 1, 1990
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myelomaC Shimazaki, J Fried, A G Perez, et al.
Leukemia|December 8, 2016
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigenS Rafiq, T J Purdon, A F Daniyan, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activityL C Pagliaro, B Liu, R Munker, et al.
Molecular Immunology|August 1, 1995
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityT K Nikula, M Bocchia, M J Curcio, et al.
Nuclear Medicine and Biology|April 1, 1995
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.
Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.
Leukemia Research|May 1, 1997
Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cellsM Bocchia, Q Xu, U Wesley, et al.
Leukemia|January 1, 1996
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemiaP G Maslak, M A Weiss, E Berman, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
The Journal of Experimental Medicine|June 1, 1996
The multidrug resistance phenotype confers immunological resistanceJ H Weisburg, M Curcio, P C Caron, et al.
Acta Haematologica|January 1, 1990
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myelomaC Shimazaki, J Fried, A G Perez, et al.
Leukemia|December 8, 2016
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigenS Rafiq, T J Purdon, A F Daniyan, et al.
Pageof 13